AstraZeneca Pharma India Limited announced plans to launch Palivizumab (Synagis) in India this October. The company’s stocks were trading at ₹6,730, up by...
).push({});
]
ADCs are targeted cancer drugs that in recent years have become some of the most promising treatments for everything from breast to lung...
